About this event

  • Date and time Tue 9 Feb 2021 from 6:00pm to 8:00pm
  • Location Online
  • Organised by Respiratory Medicine

The aim of this webinar is to teach healthcare professionals about the current and future use of personalised medicine in Cystic Fibrosis (CF) and Bronchiectasis. Delegates will hear from world-leading clinical academics on the topics of CF in children, CF in adults and bronchiectasis. Discussions will include the most recent clinical trial data, to ensure that all viewers are familiar with the latest evidence-based medicine in CF and bronchiectasis.

The learning objectives will be as follows: 

  • To learn about the most recent clinical trial data regarding the use of triple therapy in cystic fibrosis 
  • To learn about advances in personalised medicine in bronchiectasis, including the use of targeted antibiotics  
  • Via the use of case-based discussion, to learn how to apply personalised medicine in clinical practice 

A CPD certificate with CPD credit will be issued to those joining each webinar live and will be automatically issued after 7 days  to those who watched the webinar live in its entirety. Those who watch the webinar on-demand will receive a CPD certificate 30 days after the webinar has gone live.  

Join in the conversation online using #RSMLive 
Follow us on Twitter: @RoySocMed 

We would like to thank our sponsor PARI for their support of this webinar. Please note that the scientific programme and content has not been influenced in any way by the sponsor.

Tickets

Standard pricing available until 09 February 2021.

Member

RSM Member RSM Student RSM Trainee
£0.00 £0.00 £0.00

Non - Member

Non - Member Student Trainee
£0.00 £0.00 £0.00

Key speakers

James Chalmers

Professor James Chalmers

Professor of Respiratory Medicine at University of Dundee; British Lung Foundation Chair of Respiratory Research 

Speaker's biography

Prof James Chalmers is a Professor and Consultant Respiratory Physician at the University of Dundee. He is also the BLF Chair of Respiratory Research. James' research focuses on developing personalised approaches in the management of bronchiectasis. He has published extensively and delivered numerous international talks about this topic.

Professor Jane Davies

Professor of Paediatric Respiratory Medicine at the National Heart and Lung Institute; Clinical Lead of the UK CF Gene Therapy Consortium

Speaker's biography

Professor Jane Davies is a Professor and Consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital. Jane's research focuses on developing targeted therapies for cystic fibrosis, and she has been involved in numberous clinical trials in this area. She is also the lead of the UK CF Gene Therapy consortium.

Steven Rowe

Professor Steven Rowe

Professor or Pulmonary, Allergy and Critical Care Medicine; Director of the Cystic Fibrosis Research Centre

Speaker's biography

Professor Steven Rowe is a Professor and respiratory paediatrician. He is a world-leading expert in cystic fibrosis, and has been at the forefront of numerous clinical trials of CFTR modulator therapies. As Director of the Cystic Fibrosis Research Centre, Steven has extensive experience in the field of personalised medicine in cystic fibrosis.

Agenda

View the programme 09 February 2021

Welcome and introduction
Personalised Medicine in Bronchiectasis

Professor James Chalmers Professor of Respiratory Medicine at University of Dundee; British Lung Foundation Chair of Respiratory Research

Personalised Medicine in Cystic Fibrosis

Professor Jane Davies - Professor of Paediatric Respiratory Medicine at the National Heart and Lung Institute; Clinical Lead of the UK CF Gene Therapy Consortium

Personalised Medicine in Cystic Fibrosis - Cases

Professor Steven Rowe - Professor or Pulmonary, Allergy and Critical Care Medicine; Director of the Cystic Fibrosis Research Centre

Panel Discussion
Close

Sponsors

Location

Online

*Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.